Trulicity 0.75 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFL7U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,152
Award facts
- Contract value 100% obligated
- $22,152.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,152.20 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, for the supply of Trulicity 0.75 mg/0.5 mL pens with an ultimate completion date of January 30, 2026. This non-set-aside contract represents a purchase order for the diabetes medication to support federal healthcare needs. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency's supply chain.
This delivery order is issued under Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with the DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2031), which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the company to supply a wide range of pharmaceutical products, medical supplies, specialty medications, and vaccines to support military healthcare programs worldwide, including deliveries to the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. The contract award demonstrates Amerisourcebergen's capability to meet federal procurement requirements through open competition and its established role as a primary pharmaceutical vendor for federal government healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FFL7U?
SPE2DR26FFL7U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FFL7U worth?
The government has obligated $22,152 on SPE2DR26FFL7U.
Is contract SPE2DR26FFL7U an order under another contract?
Yes. SPE2DR26FFL7U is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL7U competed?
The extent of competition for SPE2DR26FFL7U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award